Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Non Operating Income: 2021-2024

Historic Non Operating Income for Agios Pharmaceuticals (AGIO) over the last 4 years, with Dec 2024 value amounting to $6.5 million.

  • Agios Pharmaceuticals' Non Operating Income fell 95.94% to $67,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 47.30%. This contributed to the annual value of $6.5 million for FY2024, which is 7.13% up from last year.
  • As of FY2024, Agios Pharmaceuticals' Non Operating Income stood at $6.5 million, which was up 7.13% from $6.1 million recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Non Operating Income high stood at $14.4 million for FY2021, and its period low was $6.1 million during FY2023.
  • Its 3-year average for Non Operating Income is $6.4 million, with a median of $6.5 million in 2024.
  • Per our database at Business Quant, Agios Pharmaceuticals' Non Operating Income plummeted by 53.24% in 2022 and then rose by 7.13% in 2024.
  • Over the past 4 years, Agios Pharmaceuticals' Non Operating Income (Yearly) stood at $14.4 million in 2021, then plummeted by 53.24% to $6.7 million in 2022, then declined by 10.28% to $6.1 million in 2023, then increased by 7.13% to $6.5 million in 2024.